Announcement on Convening the Q3 2026 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688321 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix
Story so far
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Drug Clinical Trial Approval Notice for NW001
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS23546 Tablets
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for CS43158 Tablets
Earlier from Shenzhen Chipscreen Biosciences
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Drug Clinical Trial Approval Notice for NW001
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS23546 Tablets
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for CS43158 Tablets
- (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes
- Announcement on Listing and Trading of Restricted Shares from 2024 Private Placement of Shares
Later from Shenzhen Chipscreen Biosciences
All Shenzhen Chipscreen Biosciences news releasesFollow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.
Follow Shenzhen Chipscreen Biosciences